Some shareholders may not want to acknowledge it and others may...

Some shareholders may not want to acknowledge it and others may want to spin it, but the fact is that the initial AstraZeneca AZD0466 trial in solid cancers was T E R M I N A T E D after 2 years.

Apparently results were so good in that indication that they terminated the trial….. ok…. whatever helps you sleep at night.

Everyone’s frustration and anger at Starpharma being 52 cents is understandable, however you would be wise to finally direct your anger and frustration at the CEO and Chairman instead. Get active, get loud and get rid of the sea anchors that are masquerading as leaders of this company.